All In MedTech

FDA Clearance Tracker · P080002-S002

FC2 FEMALE CONDOM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 23, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 23, 2017

Approved

Time to decision

479 days

Received Mar 1, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P080002-S002
Device name
FC2 FEMALE CONDOM
Applicant location
New York City, NY
Received
Mar 1, 2016
Decided
Jun 23, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080002

Device type

Device class
Class II
Regulation
21 CFR 884.5340

Every decision under product code MBU

FDA's approval statement

As written in FDA's record.

Approval for your proposed change in the formulation of the FC2 Female Condom.

Source documents

Other decisions for Clear Future, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.